help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Haluzik, M.
Right arrow Articles by Pacak, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haluzik, M.
Right arrow Articles by Pacak, K.
The Journal of Clinical Endocrinology & Metabolism Vol. 88, No. 12 5605-5608
Copyright © 2003 by The Endocrine Society

Special Feature

Effects of Hypo- and Hyperthyroidism on Noradrenergic Activity and Glycerol Concentrations in Human Subcutaneous Abdominal Adipose Tissue Assessed with Microdialysis

Martin Haluzik, Jara Nedvidkova, Vladimir Bartak, Ivana Dostalova, Petr Vlcek, Pavel Racek, Michal Taus, Stepan Svacina, Salvatore Alesci and Karel Pacak

Third Department of Medicine (M.H., S.S.), First Faculty of Medicine; Nuclear Medicine Department (P.R., P.V.), Second Faculty of Medicine; and Outpatient Endocrine Clinic (M.T.), Prague, Czech Republic; Institute of Endocrinology (J.N., V.B., I.D.), Prague, Czech Republic 11694; Pediatric and Reproductive Endocrinology Branch (S.A., K.P.), National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892 20892-1583; and Clinical Neuroendocrinology Branch (S.A.), National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland 20892

Address all correspondence and requests for reprints to: Karel Pacak, M.D., Ph.D., DSc Chief, Unit on Clinical Neuroendocrinology, Building 10, Room 9D42, National Institute of Child Health and Human Development, National Institutes of Health, 10 Center Drive, MSC-1583, Bethesda, Maryland 20892-1583. E-mail: karel{at}mail.nih.gov.


   Abstract
Top
 Abstract
Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
Thyroid hormones play a major role in lipid metabolism. However, whether they directly affect lipolysis locally in the adipose tissue remains unknown. Therefore, we measured abdominal sc adipose tissue norepinephrine (NE), basal, and isoprenaline-stimulated lipolysis in 12 hypothyroid patients (HYPO), six hyperthyroid patients (HYPER), and 12 healthy controls by in vivo microdialysis.

Adipose tissue NE was decreased in HYPO and increased in HYPER compared with controls (90.4 ± 2.9 and 458.0 ± 69.1 vs. 294.9 ± 19.5 pmol/liter, P < 0.01). Similarly, basal lipolysis, assessed by glycerol assay, was lower in HYPO and higher in HYPER than in controls (88.2 ± 9.9 and 566.0 ± 42.0 vs. 214.3 ± 5.1 µmol/liter P < 0.01). The relative magnitude of isoprenaline-induced glycerol increase was smaller in HYPO (39 ± 19.4%, P < 0.05 vs. basal) and higher in HYPER (277 ± 30.4%, P < 0.01) than in controls (117 ± 5.6%, P < 0.01). The corresponding changes in NE after isoprenaline stimulation were as follows: 120 ± 9.2% (P < 0.05), 503 ± 113% (P < 0.01), and 267 ± 17.2 (P < 0.01).

In summary, by affecting local NE levels and adrenergic postreceptor signaling, thyroid hormones may influence the lipolysis rate in the abdominal sc adipose tissue.


   Introduction
Top
 Abstract
 Introduction
Subjects and Methods
 Results
 Discussion
 References
 
THYROID HORMONES (THs) exert several important metabolic actions, including lipolysis enhancement (1). Hyperthyroid (HYPER) states result in increased oxygen consumption, thermogenesis, and lipid mobilization, whereas hypothyroid (HYPO) states are accompanied by decreased oxygen consumption and energy expenditure (2). Metabolic changes induced by THs are accomplished in part directly, through specific nuclear receptors expressed in target tissues, and indirectly, by modulation of other hormones’ action (3). Some of the symptoms most typically associated with HYPER/HYPO states, such as tachy/bradycardia and increased/decreased perspiration, may reflect increased/ decreased sympathetic activity. Although it has been previously reported that THs can amplify catecholamine actions in different tissues, the exact mechanism of this effect is not entirely understood (1, 4).

Catecholamines are released from neural endings in the sc adipose tissue, where glycerol is released after lipolysis of triacylglycerols (5, 6). There is evidence that the lipolytic effect of THs may be, at least in part, mediated by catecholamines. Animal studies have shown that THs can influence the adrenergic activities of brown and white adipose tissue through modulation of postreceptor signaling events, including adenylate cyclase activity (4, 7, 8). Moreover, increased/decreased lipolytic response to norepinephrine (NE) was detected in cultured adipocytes derived from HYPER/HYPO patients. The increased lipolytic response was accompanied by a 2-fold increase in the number of adipocyte ß-adrenergic binding sites (9). More recently, increased abdominal and femoral adipose tissue lipolysis was demonstrated in HYPER patients in vivo (10). Despite this evidence, it remains unknown if altered thyroid function is associated with local changes in abdominal sc fat catecholamine levels or not.

A relatively new approach used in an effort to gain a better understanding of tissue metabolism is the measurement and quantification of compounds in the interstitial space. This is accomplished by using the microdialysis technique that is based on the principle of diffusion through a semipermeable membrane (11). True equilibrium can be accomplished across the membrane when low flow rates are used (12). Microdialysis can be used to monitor for changes in the flux of different molecules from the interstitial fluid to the dialysate and has been applied to a large number of human tissues since it was first introduced (13, 14, 15, 16, 17).

In the present study, we used in vivo microdialysis to investigate possible changes in NE concentration and NE-stimulated lipolysis measured as changes of local glycerol concentrations in the abdominal sc adipose tissue of HYPER and HYPO patients and healthy individuals.


   Subjects and Methods
Top
 Abstract
 Introduction
 Subjects and Methods
Results
 Discussion
 References
 
Study subjects

Twelve HYPO women [age, 41.4 ± 14 yr; body mass index (BMI), 28.6 ± 2.1 kg/m2; mean ± SEM], six HYPER women (age, 36.8 ± 12.6 yr; BMI, 20.6 ± 1.9 kg/m2) and 12 healthy women (age: 32.0 ± 10 yr; BMI: 23 ± 1.9 kg/m2), were included in this study. Only untreated patients newly diagnosed as HYPO and HYPER were included into the present study. All patients were studied a few days after the diagnosis of thyroid dysfunction. After the study was carried out, all patients were given appropriate medication.

All participants were nonsmokers, had no history of allergies, and had been free of medication for at least 2 wk before the study. Healthy volunteers had no history of obesity, thyreopathies, gastrointestinal disease, eating disorders, or other psychiatric disorders, and normal physical exam and electrocardiogram. Blood tests confirmed normal blood count, liver, and renal functions. Except for thyroid disorders, all patients were clinically stable, not suffering from any major health problems that could affect their nutritional status such as gastrointestinal disease, eating disorders, or other psychiatric disorder. Upon enrollment, all subjects were placed on a low monoamine diet.

Written informed consent was provided by all participants before being enrolled in the study, which was approved by the Human Ethical Review Committee, Institute of Endocrinology, Prague, Czech Republic.

Blood and microdialysate sampling

All subjects were studied while resting supine on a comfortable bed in a room kept at 23–25 C. At 0800 h, after overnight fasting, a venous catheter was placed in the antecubital vein and a CMA-60 catheter with cut-off of 20 kDa (CMA Microdialysis, Stockholm, Sweden) was inserted sc under sterile conditions (8–10 cm left to the umbilicus, at least 45 min before blood and microdialysate sampling). Sterile Ringer buffer was used as perfusate. After insertion of the CMA-60 catheter, perfusion with Ringer solution supplemented with 50 mmol/liter of ethanol was started at a flow rate of 2 µl/min using CMA 107 microdialysis pumps (CMA Microdialysis). Microdialysate samples were collected every 30 min over a 2-h period, 1 h before (basal condition) and 1 h after (stimulated condition) local administration of the ß1,2-adrenergic agonist isoprenaline (Saventrine, 0.1 mmol/liter, Pharmax, Bexley, Kent, UK). Microdialysate samples for catecholamine determination were collected into microvials containing preserving agents (0.2 N of acetic acid and 0.04 mol/liter of H3PO4). Both blood and microdialysate samples were placed on ice immediately after collection and stored at -80 C until being analyzed.

Hormonal and biochemical assays

NE concentration in plasma and microdialysate samples was measured by HPLC with electrochemical detection after batch alumina extraction as previously described (18).

Serum total free (f) and total (T) T3 and T4 were assayed by commercially available RIA kits (Immunotech, Prague, Czech Republic). TSH was measured with an electrochemiluminescence method (Elecsis 2010, Roche, Basel, Switzerland), the sensitivity of TSH assay was 0.005 mU/liter. Glycerol was measured colorimetrically with a commercial kit (Randox).

Changes in sc abdominal adipose tissue blood flow were determined using the ethanol dilution technique, based on the Fick’s principle (11). According to this method, differences between ethanol concentration in the perfusate (inflow) and in the dialysate (outflow) reflect changes in blood flow. Ethanol was measured using a standard enzymatic assay (Sigma Diagnostics, St. Louis, MO). For simplicity, the microdialysate ethanol concentration/ perfusate ethanol concentration ratio is referred to as "ethanol ratio."

Statistical analysis

Results are presented as mean values ± SEM. Differences between basal and isoprenaline-stimulated lipolysis were analyzed by paired t tests. Differences between groups of subjects were analyzed by ANOVA, followed by Student-Newman-Keuls post hoc test. The level of statistical significance was set at P < 0.05.


   Results
Top
 Abstract
 Introduction
 Subjects and Methods
 Results
Discussion
 References
 
Clinical, anthropometric, and major laboratory characteristics of HYPER, HYPO, and control subjects are summarized in Table 1Go. HYPER/HYPO patients had significantly lower/ higher BMI, than controls, respectively. Heart rate was significantly higher in HYPER patients compared with both HYPO patients and control subjects (Table 1Go).


View this table:
[in this window]
[in a new window]
  		TABLE 1. Clinical, anthropometric, and major laboratory characteristics of the HYPO, HYPER, and healthy control (HC) subjects enrolled in this study

 
HYPO patients had significantly lower TT3, fT3, TT4, fT4 levels, and significantly higher serum TSH and plasma NE levels compared with control subjects (Table 1Go). As expected, hyperthyroidism resulted in suppressed TSH and markedly increased TT3, fT3, TT4, and fT4 levels. No differences in plasma NE levels were found between HYPER and control subjects (Table 1Go). Serum glycerol levels were significantly lower in HYPO and higher in HYPER patients relative to control subjects. Free fatty acids were higher in HYPER patients than in both HYPO patients and control subjects. In contrast, no significant differences among the experimental groups were found in plasma glucose and serum insulin levels (Table 1Go).

Ethanol ratios were similar in controls and HYPO patients, whereas they were significantly decreased in HYPER patients in comparison to both controls (P < 0.05) and HYPO (P < 0.05) (Fig. 1Go).



View larger version (19K):
[in this window]
[in a new window]
  		FIG. 1. Ethanol ratio (dialysate ethanol concentration/perfusate ethanol concentration) in healthy control, HYPO, and HYPER subjects. Results are presented as means ± SEM. *, P < 0.05 vs. healthy controls; +, P < 0.05 vs. HYPO subjects.

 
Compared with glycerol and NE values measured in healthy subjects (214.3 ± 5.1 µmol/liter and 294.9 ± 19.5 pmol/liter, respectively) basal sc fat glycerol and NE levels were significantly lower in HYPO (88.2 ± 9.9 µmol/liter, P < 0.01; and 90.4 ± 2.9 pmol/liter, P < 0.01, respectively), and higher in HYPER patients (566 ± 42 µmol/liter, P < 0.01 and 458.0 ± 69.1 pmol/liter, P < 0.01, respectively) (Figs. 2Go and 3Go). Compared with basal values, local isoprenaline administration induced a significant increase of both glycerol and NE levels in controls (466.2 ± 12 µmol/liter, P < 0.01 and 1082.7 ± 50.8 pmol/liter, P < 0.001, respectively), as well as in HYPO (123.0 ± 10.2 µmol/liter, P < 0.05 and 199.7 ± 8.4 pmol/liter, P < 0.01, respectively), and HYPER patients (2135.0 ± 172.0 µmol/liter, P < 0.01 and 2765.8 ± 521.8 pmol/liter, P < 0.001, respectively) (Figs. 2Go and 3Go). The relative magnitude of the isoprenaline-induced increase in glycerol levels was significantly smaller in HYPO (39 ± 19.4%, P < 0.05) and higher in HYPER (277 ± 30.4%, P < 0.01) than in controls (117 ± 5.6%, P < 0.01). Local changes in NE concentrations after isoprenaline stimulation followed a similar pattern in all three groups: 267 ± 17.2% of increase in the control group, 120 ± 9.2% in HYPO (P < 0.05), and 503 ± 113% in HYPER patients (P < 0.01).



View larger version (15K):
[in this window]
[in a new window]
  		FIG. 2. Glycerol concentration in the abdominal sc fat tissue during basal conditions and after isoprenaline-stimulated lipolysis in healthy control (HC), HYPO, and HYPER subjects. Results are presented as scatter plots of individual values with bars showing means. *, P < 0.01 vs. healthy controls; +, P < 0.01 vs. HYPO subjects.

 


View larger version (15K):
[in this window]
[in a new window]
  		FIG. 3. Norepinephrine concentration in the abdominal sc fat tissue during basal conditions and after isoprenaline-stimulated lipolysis in healthy control (HC), HYPO, and HYPER subjects. Results are presented as scatter plots of individual values with bars showing means. *, P < 0.01 vs. healthy controls; +, P < 0.01 vs. HYPO subjects.

 

   Discussion
Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
References
 
Normal thyroid function is essential to regulate lipid metabolism. It is, however, uncertain whether THs directly affect lipolysis in the sc adipose tissue and to what extent those changes may overall contribute to determine the metabolic phenotype of patients with thyroid dysfunctions. Our study was designed to determine local noradrenergic activity and basal and isoprenaline-stimulated lipolysis in the abdominal sc adipose tissue of patients with thyroid dysfunctions.

We found that the thyroid functional status strongly influences both the noradrenergic and lipolytic activities of sc abdominal adipose tissue in vivo. HYPO patients displayed significantly decreased sc fat NE and glycerol concentrations compared with healthy subjects, whereas the opposite applied to HYPER patients.

The parallel changes in basal sc fat levels of NE and glycerol observed in patients with thyroid dysfunctions suggest that altered lipolysis in these subjects may result from local modification in adrenergic activity. We suggest that one explanation of this finding is the effect of the thyroid status on the adrenergic receptors number and sensitivity (5, 6, 19). Alternatively, adrenergic postreceptor signaling in the adipose tissue may be involved on multiple levels, including adenylate cyclase activity (7, 9, 20).

Isoprenaline-stimulated lipolysis was also less pronounced in HYPO patients than in healthy controls. It is, therefore, likely that the altered lipolytic response in patients with thyroid disorders results from a combination of local NE changes and other mechanisms, including modulation of other lipolysis regulating hormones or enzymes by THs. For example, THs have been shown to influence the lipolytic action of growth hormone (21) and directly affect the activity of hormone sensitive lipase in adipose tissue (22). Moreover, the adipose tissue itself produces a number of hormones, such as leptin, adiponectin, resistin, and others, that can influence local lipolysis and/or triglyceride synthesis through paracrine mechanisms (23, 24, 25). However, no information is currently available regarding the effect of THs on the adipose tissue paracrine functions in vivo.

We found a discrepancy between local and systemic NE levels in both HYPO and HYPER patients. In fact, our group and others had previously shown that hypothyroidism is accompanied by increased systemic NE levels, whereas no change in this parameter was found in HYPER patients (1, 26). The possible explanation for this discrepancy could be that plasma NE concentration reflects the net amount of this hormone released from different tissues, whereas microdialysate NE concentration measures the quantity released in adipose tissue. Local blood flow in our study was significantly higher in HYPER and unchanged in HYPO patients compared with controls. Thus, if anything, increased local blood flow would cause higher NE outflow from adipose associated with low NE sc abdominal adipose tissue concentrations (27). Therefore, higher sc fat NE levels in HYPER patients result from increased sympathetic activity in sc abdominal adipose. This suggestion is further supported by other studies showing that the role of systemic catecholamines in the regulation of adipose tissue lipolysis is only minor relative to that of catecholamines locally released from sympathetic nerve endings (28, 29).

In summary, in the present study we demonstrated that altered thyroid function is accompanied by changes in abdominal sc fat adrenergic and lipolytic activities, which may explain some of the phenotypic features observed in patients with functional thyroid disorders.


   Acknowledgments
 
We thank Ms. Diana Riegerova, Jana Novotna, Romana Bajtlova, Christina Kukura, and Shiromi Perera for their technical assistance.


   Footnotes
 
The study was supported by a grant agency of the Czech Republic, GACR, no. 303/00/1555.

Abbreviations: BMI, Body mass index; fT3 and fT4, serum free T3 and T4; HYPER, hyperthyroid; HYPO, hypothyroid; NE, norepinephrine; TT3 and TT4, total T3 and T4; TH, thyroid hormone.

Received April 4, 2003.

Accepted June 14, 2003.


   References
Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 

  1. Levey GS, Klein I 1990 Catecholamine-thyroid hormone interactions and the cardiovascular manifestations of hyperthyroidism. Am J Med 88:642–646[CrossRef][Medline]
  2. Duntas LH 2002 Thyroid disease and lipids. Thyroid 12:287–293[CrossRef][Medline]
  3. Brent GA 2000 Tissue-specific actions of thyroid hormone: insights from animal models. Rev Endocr Metab Disord 1:27–33[CrossRef][Medline]
  4. Rubio A, Raasmaja A, Maia AL, Kim KR, Silva JE 1995 Effects of thyroid hormone on norepinephrine signaling in brown adipose tissue. I. ß1- and ß2-Adrenergic receptors and cyclic adenosine 3', 5'-monophosphate generation. Endocrinology 136:3267–3276[Abstract]
  5. Londos C, Brasaemle DL, Schultz CJ, Adler-Wailes DC, Levin DM, Kimmel AR, Rondinone CM 1999 On the control of lipolysis in adipocytes. Ann NY Acad Sci 892:155–168[Abstract/Free Full Text]
  6. Langin D, Lucas S, Lafontan M 2000 Millennium fat-cell lipolysis reveals unsuspected novel tracks. Horm Metab Res 32:443–452[Medline]
  7. Chaudhry A, Granneman JG 1997 Effect of hypothyroidism on adenylyl cyclase activity and subtype gene expression in brown adipose tissue. Am J Physiol 273:R762–R767
  8. Rubio A, Raasmaja A, Silva JE 1995 Thyroid hormone and norepinephrine signaling in brown adipose tissue. II: Differential effects of thyroid hormone on ß 3-adrenergic receptors in brown and white adipose tissue. Endocrinology 136:3277–3284[Abstract]
  9. Wahrenberg H, Wennlund A, Arner P 1994 Adrenergic regulation of lipolysis in fat cells from hyperthyroid and hypothyroid patients. J Clin Endocrinol Metab 78:898–903[Abstract]
  10. Riis AL, Gravholt CH, Djurhuus CB, Norrelund H, Jorgensen JO, Weeke J, Moller N 2002 Elevated regional lipolysis in hyperthyroidism. J Clin Endocrinol Metab 87:4747–4753[Abstract/Free Full Text]
  11. Fellander G, Linde B, Bolinder J 1996 Evaluation of the microdialysis ethanol technique for monitoring of subcutaneous adipose tissue blood flow in humans. Int J Obes Relat Metab Disord 20:220–226[Medline]
  12. Rosdahl H, Hamrin K, Ungerstedt U, Henriksson J 1998 Metabolite levels in human skeletal muscle and adipose tissue studied with microdialysis at low perfusion flow. Am J Physiol 274:E936–E945
  13. Lonnroth P, Jansson PA, Smith U 1987 A microdialysis method allowing characterization of intercellular water space in humans. Am J Physiol 253:E228–E231
  14. Bruce S, Tack C, Patel J, Pacak K, Goldstein DS 2002 Local sympathetic function in human skeletal muscle and adipose tissue assessed by microdialysis. Clin Auton Res 12:13–19[CrossRef][Medline]
  15. Kennergren C, Mantovani V, Strindberg L, Berglin E, Hamberger A, Lonnroth P 2003 Myocardial interstitial glucose and lactate before, during, and after cardioplegic heart arrest. Am J Physiol Endocrinol Metab 284:E788–E794
  16. Meixensberger J, Kunze E, Barcsay E, Vaeth A, Roosen K 2001 Clinical cerebral microdialysis: brain metabolism and brain tissue oxygenation after acute brain injury. Neurol Res 23:801–806[CrossRef][Medline]
  17. Dabrosin C 2001 Technical aspects of microdialysis of human breast. Scand J Clin Lab Invest 61:269–272[CrossRef][Medline]
  18. Pacak K, Palkovits M, Yadid G, Kvetnansky R, Kopin IJ, Goldstein DS 1998 Heterogeneous neurochemical responses to different stressors: a test of Selye’s doctrine of nonspecificity. Am J Physiol 275:R1247–R1255
  19. Richelsen B, Sorensen NS 1987 {alpha}2- and ß-Adrenergic receptor binding and action in gluteal adipocytes from patients with hypothyroidism and hyperthyroidism. Metabolism 36:1031–1039[CrossRef][Medline]
  20. Hellstrom L, Wahrenberg H, Reynisdottir S, Arner P 1997 Catecholamine-induced adipocyte lipolysis in human hyperthyroidism. J Clin Endocrinol Metab 82:159–166[Abstract/Free Full Text]
  21. Richelsen B 1997 Action of growth hormone in adipose tissue. Horm Res 48(Suppl)5:105–110
  22. Kern PA, Ranganathan G, Yukht A, Ong JM, Davis RC 1996 Translational regulation of lipoprotein lipase by thyroid hormone is via a cytoplasmic repressor that interacts with the 3' untranslated region. J Lipid Res 37:2332–2340[Abstract]
  23. Minokoshi Y, Kim YB, Peroni OD, Fryer LG, Muller C, Carling D, Kahn BB 2002 Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415:339–343[CrossRef][Medline]
  24. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA 2001 The hormone resistin links obesity to diabetes. Nature 409:307–312[CrossRef][Medline]
  25. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn BB, Kadowaki T 2002 Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8:1288–1295[CrossRef][Medline]
  26. Vavrejnova V, Nedvidkova J, Husek P, Zamrazil V, Nemec J 1992 Increased levels of noradrenaline in hypothyroidism and its association with cardiovascular system function. Vnitr Lek 38:1195–1200[Medline]
  27. Nonogaki K 2000 New insights into sympathetic regulation of glucose and fat metabolism. Diabetologia 43:533–549[CrossRef][Medline]
  28. Lafontan M, Berlan M 1993 Fat cell adrenergic receptors and the control of white and brown fat cell function. J Lipid Res 34:1057–1091[Abstract]
  29. Barbe P, Galitzky J, Riviere D, Senard JM, Lafontan M, Garrigues M, Berlan M 1993 Effects of physiological and pharmacological variation of sympathetic nervous system activity on plasma non-esterified fatty acid concentrations in man. Br J Clin Pharmacol 36:25–30[Medline]



This article has been cited by other articles:


Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
L. P. Klieverik, H. P. Sauerwein, M. T. Ackermans, A. Boelen, A. Kalsbeek, and E. Fliers
Effects of thyrotoxicosis and selective hepatic autonomic denervation on hepatic glucose metabolism in rats
Am J Physiol Endocrinol Metab, March 1, 2008; 294(3): E513 - E520.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
E. Ortega, N. Pannacciulli, C. Bogardus, and J. Krakoff
Plasma concentrations of free triiodothyronine predict weight change in euthyroid persons
Am. J. Clinical Nutrition, February 1, 2007; 85(2): 440 - 445.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
G. Dimitriadis, P. Mitrou, V. Lambadiari, E. Boutati, E. Maratou, D. B. Panagiotakos, E. Koukkou, M. Tzanela, N. Thalassinos, and S. A. Raptis
Insulin Action in Adipose Tissue and Muscle in Hypothyroidism
J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 4930 - 4937.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
G. Dimitriadis, P. Mitrou, V. Lambadiari, E. Boutati, E. Maratou, E. Koukkou, M. Tzanela, N. Thalassinos, and S. A. Raptis
Glucose and Lipid Fluxes in the Adipose Tissue after Meal Ingestion in Hyperthyroidism
J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 1112 - 1118.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. N. Mariash
Thyroid Hormone and the Adipocyte
J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5603 - 5604.
[Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Haluzik, M.
Right arrow Articles by Pacak, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haluzik, M.
Right arrow Articles by Pacak, K.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals